Wolverine Trading, LLC Aurinia Pharmaceuticals Inc. Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	BUY	$8.96 - $11.69 $118,451 - $154,541	13,220 New	13,220 $127,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $466,062 - $666,547	-52,074 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $25,356 - $56,717	-2,523 Reduced 4.62%	52,074 $645,000
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $147,200 - $273,869	8,279 Added 17.87%	54,597 $1.24 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $506,255 - $1.09 Million	46,318 New	46,318 $1.07 Million

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.